Metabolomic signatures mediate the association between physical frailty and metabolic dysfunction-associated steatotic liver disease: a prospective cohort study - Summary - MDSpire
Advertisement
Metabolomic signatures mediate the association between physical frailty and metabolic dysfunction-associated steatotic liver disease: a prospective cohort study
To identify a frailty-related metabolic signature and examine its association with incident metabolic dysfunction-associated steatotic liver disease (MASLD), highlighting the significance of understanding this relationship.
Key Findings:
Over a median follow-up of 13.7 years, 3,408 incident MASLD cases occurred.
A 96-metabolite signature was identified, with each 1-standard deviation increase associated with a 21% higher MASLD risk (HR = 1.21, 95% CI: 1.16-1.25).
Pre-frail and frail individuals had HRs of 1.51 (95% CI: 1.40-1.63) and 2.22 (95% CI: 1.97-2.50) for MASLD, respectively.
The metabolic signature mediated 4.25% of the frailty-MASLD association.
Interpretation:
Frailty and its associated metabolic signature are independently linked to increased risk of incident MASLD, with the signature partially mediating this relationship, indicating metabolic dysregulation as a connection between physical frailty and hepatic steatosis. Further implications of these findings should be discussed.
Limitations:
The study is observational, limiting causal inferences.
The cohort is predominantly of European descent, which may affect generalizability. More context on the impact of this limitation should be provided.
Conclusion:
Identifying the frailty-related metabolic signature may enable earlier detection of MASLD in frail individuals, highlighting the importance of metabolic dysregulation in the frailty-MASLD relationship and its potential clinical applications.
